BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 37303221)

  • 21. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
    São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
    Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
    Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
    J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
    Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
    JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer predisposition and germline CTNNA1 variants.
    Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
    Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
    Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
    Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
    Graziano F; Humar B; Guilford P
    Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
    Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
    J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study.
    Bardram L; Hansen TV; Gerdes AM; Timshel S; Friis-Hansen L; Federspiel B
    Fam Cancer; 2014 Jun; 13(2):231-42. PubMed ID: 24389957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
    Melo S; Figueiredo J; Fernandes MS; Gonçalves M; Morais-de-Sá E; Sanches JM; Seruca R
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene].
    Van Domselaar F; Correa D; Vaccaro C; Redal M; Van Domselaar R; Huntsman D; Kaurah P; Senz J; Lynch H
    Acta Gastroenterol Latinoam; 2007 Sep; 37(3):158-63. PubMed ID: 17955726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and cancer risk in families with pathogenic
    Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
    J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review.
    Goud HK; Mehkari Z; Mohammed L; Javed M; Althwanay A; Ahsan F; Oliveri F; Rutkofsky IH
    Cureus; 2020 Sep; 12(9):e10406. PubMed ID: 33062523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic laparoscopic-assisted total gastrectomy for hereditary diffuse gastric cancer.
    Francis WP; Rodrigues DM; Perez NE; Lonardo F; Weaver D; Webber JD
    JSLS; 2007; 11(1):142-7. PubMed ID: 17651578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
    Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
    J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of the factors effecting high-risk individuals' decision-making about prophylactic total gastrectomy and surveillance for hereditary diffuse gastric cancer (HDGC).
    Hallowell N; Badger S; Richardson S; Caldas C; Hardwick RH; Fitzgerald RC; Lawton J
    Fam Cancer; 2016 Oct; 15(4):665-76. PubMed ID: 27256430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.